FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Dont Use Quidel Triage Cardiac Panel: FDA

FDA says healthcare providers, laboratories, and facilities should immediately stop using the Quidel Triage Cardiac Panel due to inaccurate results th...

latest-news-card-1
Human Drugs

Ex-FDA Gene Therapy Guru Joins Greenleaf

Former CBER Office of Tissues and Advanced Therapies director Wilson Bryan joins regulatory consulting firm Greenleaf Health as executive vice presid...

latest-news-card-1
Medical Devices

8 Repeat QS Violations at Edge Biologicals

FDA warns Memphis, TN-based Edge Biologicals about eight repeated Quality System violations in its manufacturing of in vitro diagnostics.

latest-news-card-1
Human Drugs

Ambrx Gets Fast Track for Prostate Cancer Drug

FDA grants Ambrx Biopharma a fast track designation for ARX517 for treating certain patients with metastatic castration-resistant prostate cancer.

Medical Devices

Nitric Oxide Delivery Device Recalled

NOxBOX recalls its NOxBOXi Nitric Oxide Delivery System due to a check valve misalignment in the devices manifold.

latest-news-card-1
Medical Devices

FDA Clears ReddyPort Ventilation Device

FDA clears the ReddyPort elbow device used in non-invasive ventilation.

latest-news-card-1
Human Drugs

4 Observations in SCA Pharmaceuticals FDA-483

FDA releases the form FDA-483 issued following an inspection at the Little Rock, AR-based SCA Pharmaceuticals outsourcing facility.

Human Drugs

Keytruda Hits Endpoint in Cervical Cancer Trial

Mercks Keytruda with concurrent chemoradiotherapy meets the progression-free survival primary endpoint in an interim analysis of the KEYSTONE A-18 cer...

latest-news-card-1
Human Drugs

FDA Clears Xstrahl Skin Cancer Radiation Therapy

FDA clears an Xstrahl 510(k) for its Radiant Aura treatment device for providing radiation therapy to non-melanoma skin cancer patients.

latest-news-card-1
Human Drugs

FDA Grants Fast Track for Myelofibrosis Drug

FDA grants Karyopharm Therapeutics fast track status for selinexor for treating patients with myelofibrosis.